Search
Meeting Overview:
Transforming Tumor Profiling into Targeted Patient Care.
Precision oncology is rapidly changing the landscape of cancer care. With FDA approvals shifting toward molecular features rather than disease location, personalized treatment is no longer just a goal—it’s the standard.
However, with diagnostic technologies and targeted therapies evolving at a breathtaking pace, keeping up with clinical applications remains a challenge. Join ANCO & MOASC for an immersive symposium designed to help practicing oncologists and clinical care teams bridge the gap between cutting-edge diagnostics and patient outcomes.
Learning Objectives:
By participating this meeting, attendees will learn to:
Translate complex molecular tumor profiles and tumor-agnostic FDA approvals into personalized patient treatment plans.
Navigate current challenges and adopt new therapeutic opportunities in Gastrointestinal, Genitourinary, Lung, and Breast/Gynecologic cancers.
Utilize germline data alongside somatic diagnostic findings to guide comprehensive clinical decision-making.
Identify cross-tumor challenges in precision testing and apply best practices to overcome diagnostic barriers.
Partner with patient advocates to ensure biomarker-driven care plans remain patient-centered and accessible.
Apply to Become a Member
4225 Solano Ave, #764 Napa, CA 94558 Phone (415) 472-3960
Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer